Background: L-PRF or leucocyte-platelet-rich fibrin membrane is a newer platelet concentrate that is recently being accepted widely as an autologous healing biomaterial having properties of promoting healing and angiogenesis in sites with immediate implant placement. Aim: The present clinical study aimed to assess the soft-tissue and hard-tissue outcomes after immediate implant placement in sites with or without the use of L-PRF. Methods: The present clinical study assessed 36 sites of immediate implant placement that were randomly divided into two groups having 18 implants each where Group I had additional L-PRF and Group II did not use L-PRF with immediate implant placement. A definitive restoration was given at all the sites after 3 months of implant placement and subjects were assessed at 6 months follow-up. Results: Statistically non-significant better results were seen after using L-PRF at extraction socket sites of immediate implant placement compared to sites without the use of L-PRF concerning the radiographic and clinical parameters. Conclusion: The present study concludes that using L-PRF in immediate implant placement sites depicted marginally better results compared to the extraction sites where no L-PRF was used with immediate implant placement.